Teva Pharmaceutical Industries (TEVA) Total Debt Growth (1y) (2010 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | -3.69% |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -7.75% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 60.10% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 8.22% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | -4.47% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -4.20% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 0.56% |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.69% |
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | -5.49% |
| Sep 30, 2025 | -11.54% |
| Jun 30, 2025 | -7.59% |
| Mar 31, 2025 | -15.24% |
| Dec 31, 2024 | -10.34% |
| Sep 30, 2024 | -4.98% |
| Jun 30, 2024 | -9.85% |
| Mar 31, 2024 | -5.06% |
| Dec 31, 2023 | -6.50% |
| Sep 30, 2023 | -6.08% |
| Jun 30, 2023 | -6.36% |
| Mar 31, 2023 | -9.71% |
| Dec 31, 2022 | -7.95% |
| Sep 30, 2022 | -10.44% |
| Jun 30, 2022 | -12.14% |
| Mar 31, 2022 | -8.28% |
| Dec 31, 2021 | -11.10% |
| Sep 30, 2021 | -7.32% |